Wolfgang N. Loscher

Hannover, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 347 publications

Correction: Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy.

Correction: Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy.

Journal: CNS drugs

Published: June 18, 2026

Longitudinal multimodal assessment of peripheral nerve involvement in wild-type transthyretin amyloidosis.

Longitudinal multimodal assessment of peripheral nerve involvement in wild-type transthyretin amyloidosis.

Journal: Journal of neurology

Published: April 17, 2026

SOD1 Variants in Patients With Amyotrophic Lateral Sclerosis in Central Eastern Europe: From Genetic Testing to SOD1 Targeted Therapy.

SOD1 Variants in Patients With Amyotrophic Lateral Sclerosis in Central Eastern Europe: From Genetic Testing to SOD1 Targeted Therapy.

Journal: European journal of neurology

Published: April 01, 2026

Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.

Hereditary Transthyretin Amyloidosis in Austria: Clinical, Genetic, and Demographic Insights from a Nationwide Cohort.

Journal: Journal of clinical medicine

Published: January 26, 2026

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Meningococcal prophylaxis in neurological diseases treated with complement inhibitors: an expert consensus for Germany, Austria, and Switzerland.

Journal: Therapeutic advances in neurological disorders

Published: December 17, 2025

A consensus roadmap for post-traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials.

A consensus roadmap for post-traumatic epilepsy: Clinical biomarkers, research priorities, policy barriers, and pathways to interventional trials.

Journal: Epilepsia

Published: November 25, 2025

Demographic, clinical and genetic characteristics of patients with amyotrophic lateral sclerosis from two specialised centres in Austria.

Demographic, clinical and genetic characteristics of patients with amyotrophic lateral sclerosis from two specialised centres in Austria.

Journal: Journal of neurology

Published: November 17, 2025

The Discovery of Cenobamate: A Drug with High Efficacy in Drug-Resistant Epilepsy.

The Discovery of Cenobamate: A Drug with High Efficacy in Drug-Resistant Epilepsy.

Journal: CNS drugs

Published: November 15, 2025

Ranking of antiseizure medications in a panel of focal seizure models predicts their comparative efficacy in clinical add-on trials in drug-resistant focal epilepsy.

Ranking of antiseizure medications in a panel of focal seizure models predicts their comparative efficacy in clinical add-on trials in drug-resistant focal epilepsy.

Journal: Epilepsia

Published: November 04, 2025

Diagnostic Value of Muscle Biopsy for the Evaluation of Adult Myopathy in Daily Clinical Practice.

Diagnostic Value of Muscle Biopsy for the Evaluation of Adult Myopathy in Daily Clinical Practice.

Journal: Diagnostics (Basel, Switzerland)

Published: November 04, 2025

Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy.

Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy.

Journal: CNS drugs

Published: October 27, 2025

Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial.

Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial.

Journal: The Lancet. Neurology

Published: September 30, 2025

Showing 1-12 of 347

Last Updated: 09/26/2026